Approvals/NMPA/Empagliflozin and Metformin Hydrochloride Sustained-release Tablets（II）

Approved

化学药品

Empagliflozin and Metformin Hydrochloride Sustained-release Tablets（II）

乐普药业股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 8mdl5JkZzhv
Approval Number: 国药准字H20263323
Generic Name: 恩格列净二甲双胍缓释片(Ⅱ)
Generic Name En: Empagliflozin and Metformin Hydrochloride Sustained-release Tablets（II）
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 恩格列净10mg和盐酸二甲双胍1000mg
Reg Date: 2026-02-02
Company Name: 乐普药业股份有限公司
Company Address: 河南省项城市平安大道东段216号
Production Company Name: 乐普药业股份有限公司
Production Company Address: 河南省项城市产业集聚区东方大道路北136号
Company Detail Path: /organization/le-pu-yao-ye-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/le-pu-yao-ye-gu-fen-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Feb 2, 2026

Approval ID

8mdl5JkZzhv

Type

化学药品